NOVEL BIOMARKER SPECIFIC FOR ACUTE MYELOID LEUKEMIA AND DRUG USING THE ANTIBODY

PURPOSE: A novel biomarker for acute myeloid leukemia is provided to diagnose acute myeloid leukemia and neutralize by specifically binding to biomarker. CONSTITUTION: A biomarker for diagnosing acute myeloid leukemia contains TM6SF1(transmembrane 6 superfamily member 1) or TM7SF3(transmembrane 7 su...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEE, JI YEUNG, KIM, SAE WON, SUNG, YOUNG CHUL, CHOI, SO YOUNG, YANG, SE HWAN
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PURPOSE: A novel biomarker for acute myeloid leukemia is provided to diagnose acute myeloid leukemia and neutralize by specifically binding to biomarker. CONSTITUTION: A biomarker for diagnosing acute myeloid leukemia contains TM6SF1(transmembrane 6 superfamily member 1) or TM7SF3(transmembrane 7 superfamily member 3) as an active ingredient. An extracellular domain of TM6SF1 specifically binds to anti-TM6SF1 antibody. The extracellular domain of TM6SF1 is encoded by a sequence of sequence number 5. An extracellular domain of TM7SF3 specifically binds to anti-TM7SF3 antibody. The extracellular domain of TM7SF3 is encoded by a sequence of sequence number 6.